Fig. 3 | Gastric Cancer

Fig. 3

From: Accuracy of upper endoscopies with random biopsies to identify patients with gastric premalignant lesions who can safely be exempt from surveillance

Fig. 3

Schematic visualization of surveillance of patients with premalignant gastric lesion according to the MAPS-2012 guideline (a), according to the MAPS-2019 guideline (b) and according to the BSG (c). LGD low-grade dysplasia; HGD high-grade dysplasia; GC gastric cancer; CI confidence interval; MAPS management of precancerous conditions and lesions in the stomach; Proregal progression and regression of precancerous lesions

Back to article page